Natus Medical Incorporated
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTUS research report →
About the company
Natus Medical Incorporated is a global provider of advanced medical device solutions, dedicated to the diagnosis and treatment of conditions affecting the central nervous and sensory systems. The company's offerings are utilized for the screening, detection, therapeutic intervention, ongoing monitoring, and tracking of a wide array of prevalent medical issues. Its product portfolio addresses critical areas such as newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disturbances, and neuromuscular diseases.
- CEO
- Jonathan Kennedy
- IPO
- 2001
- Employees
- 1,400
- HQ
- Pleasanton, CA, US
Price Chart
- Market Cap
- $0
- P/E
- 84.51
- P/S
- 0.00
- P/B
- 2.64
- EV/EBITDA
- -1.30
- Div Yield
- 0.00%
- Gross Margin
- 57.81%
- Op Margin
- 4.48%
- Net Margin
- 2.78%
- ROE
- 3.15%
- ROIC
- 3.18%
- Revenue
- $473.44M · 13.89%
- Net Income
- $13.18M · 179.32%
- EPS
- $0.39 · 179.59%
- Op Income
- $21.23M
- FCF YoY
- 133.86%
- 52W High
- $33.93
- 52W Low
- $20.90
- 50D MA
- $32.61
- 200D MA
- $27.38
- Beta
- 0.23
- Avg Volume
- 339.69K
Get TickerSpark's AI analysis on NTUS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 21, 22 | LEVINE JOSHUA | sell | 37,387 |
| Jul 21, 22 | Heine Lisa Wipperman | sell | 26,287 |
| Jul 21, 22 | Sullivan Thomas Joseph | other | 648,554 |
| Jul 21, 22 | Sullivan Thomas Joseph | sell | 720,903 |
| Jul 21, 22 | Noll Austin Francis III | other | 61,966 |
| Jul 21, 22 | Noll Austin Francis III | sell | 72,534 |
| Jul 21, 22 | Noll Austin Francis III | sell | 200,509 |
| Jul 21, 22 | CHUNG DONG CHUNE CHRISTOPHER | other | 35,056 |
| Jul 21, 22 | CHUNG DONG CHUNE CHRISTOPHER | sell | 83,374 |
| Jul 21, 22 | CHUNG DONG CHUNE CHRISTOPHER | sell | 35,360 |
Our NTUS coverage
Recent articles, reports, and earnings notes.
No research on NTUS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NTUS report →Similar companies
Peers in the same neighborhood.